Publication:
Effect of Phencyclidine on Neuregulin Expression, Cortical Interneurons, and Redox Dysregulation

Simple item page
dc.contributor.authorPetronijević, Nataša (6506911099)
dc.contributor.authorRadonjić, Nevena V. (23390243000)
dc.date.accessioned2025-06-12T18:42:24Z
dc.date.available2025-06-12T18:42:24Z
dc.date.issued2016
dc.description.abstractPhencyclidine (PCP), a dissociative anesthetic often abused as a hallucinogen, can induce schizophrenia-like psychosis, including positive and negative symptoms and cognitive dysfunction. PCP is a noncompetitive antagonist of the N-methyl-. d-aspartate receptor (NMDAR). NMDAR hypofunction has been proposed to be a critical component of the pathophysiology of schizophrenia, promoting deficits in gamma-aminobutyric acid (GABA)ergic signaling. Perinatal PCP administration to rodents represents one of the actual animal models of schizophrenia. Here, we explore acute and long-term effects of perinatal PCP administration on the expression of neuregulin-1, a putative risk gene described in schizophrenia. Furthermore, the effects of perinatal PCP treatment on the density of different subclasses of GABAergic cortical interneurons, redox homeostasis, and susceptibility of cortical interneurons to harmful effects of free radicals are discussed. © 2016 Elsevier Inc. All rights reserved.
dc.identifier.urihttps://doi.org/10.1016/B978-0-12-800212-4.00057-1
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84969674432&doi=10.1016%2fB978-0-12-800212-4.00057-1&partnerID=40&md5=be48cda5f842129ee36aeb1e9fbf4c47
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/7698
dc.subjectGABA
dc.subjectInterneurons
dc.subjectNeuregulin-1
dc.subjectPhencyclidine
dc.subjectRedox dysregulation
dc.titleEffect of Phencyclidine on Neuregulin Expression, Cortical Interneurons, and Redox Dysregulation
dspace.entity.typePublication

Files

Collections

Publikacije / Publications